Please note: We are currently experiencing some performance issues across the site, and some pages may be slow to load. We are working on restoring normal service soon. Importing new articles from Word documents is also currently unavailable. We apologize for any inconvenience.

January 24, 2023
COST-EFFECTIVENESS OF OMALIZUMAB FOR THE TREATMENT OF SEVERE PEDIATRIC ALLERGIC ASTHM...
Antonio Nieto, María Nieto-Cid, Teresa Garriga-Baraut, et al.
October 29, 2020
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent al...
Antonio Nieto García, Teresa Garriga-Baraut, Ana Maria Plaza, et al.